YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Lamictal
Epilepsy Drugs Targeted for Black Box Suicide Warning
Jul 8, 2008 | Parker Waichman Alonso LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...
New Suicide Warning for Epilepsy Drugs
Jun 12, 2008 | Parker Waichman Alonso LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior. The...
Epilepsy Drugs to Get Suicide Warnings, FDA Confirms
Jun 6, 2008 | Parker Waichman Alonso LLP
US regulators are very close to finalizing new suicide warnings for 11 epilepsy drugs, The Wall Street Journal reported today. This past...
Epilepsy Drugs Double Suicide Risks, FDA Warns
Feb 2, 2008 | Parker Waichman Alonso LLP
Epilepsy drugs have been linked to a increased risk of suicidal thoughts and behavior, the Food & Drug Administration (FDA) warned this...
Glaxo bipolar drug may be tied to defect
Sep 29, 2006 | AP
Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to...
Glaxo Bipolar Drug May Be Tied to Defects
Sep 29, 2006 | AP
Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to...
First-Trimester Exposure to Lamictal May Cause Oral Cleft
Sep 29, 2006 | Medscape
The US Food and Drug Administration (FDA) has notified healthcare professionals regarding new preliminary information from the North American...
Company notes association between anti-epileptic drug, cleft palate in babies
Aug 9, 2006 | Canadian Press
Drugmaker GlaxoSmithKline is informing pregnant women of a possible association between an anti-epileptic medication and cleft palate or cleft lip in...
Page 1/1
Defective Drugs
